Stock futures indicated a positive start of trading session, supported by a couple of takeover deals and stronger-than-expected earnings reports. Drug maker Schering-Plough reported a Q2 profit above forecasts on sharply higher sales of its cholesterol drugs. Company’s shares rose 3.9%, while rival Merck & Co gained 1.7% on earnings that beat analyst expectations. The company also raised its full-year profit forecast. |
More: